JP2024534901A5 - - Google Patents
Info
- Publication number
- JP2024534901A5 JP2024534901A5 JP2024514038A JP2024514038A JP2024534901A5 JP 2024534901 A5 JP2024534901 A5 JP 2024534901A5 JP 2024514038 A JP2024514038 A JP 2024514038A JP 2024514038 A JP2024514038 A JP 2024514038A JP 2024534901 A5 JP2024534901 A5 JP 2024534901A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- composition
- synucleinopathy
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163239505P | 2021-09-01 | 2021-09-01 | |
| US63/239,505 | 2021-09-01 | ||
| PCT/US2022/075836 WO2023034914A2 (en) | 2021-09-01 | 2022-09-01 | Methods for the prevention and treatment of synucleinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534901A JP2024534901A (ja) | 2024-09-26 |
| JP2024534901A5 true JP2024534901A5 (https=) | 2025-09-29 |
Family
ID=85413127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514038A Pending JP2024534901A (ja) | 2021-09-01 | 2022-09-01 | シヌクレイノパチーの予防及び治療のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240358806A1 (https=) |
| EP (1) | EP4395894A4 (https=) |
| JP (1) | JP2024534901A (https=) |
| KR (1) | KR20240055785A (https=) |
| CN (1) | CN118119403A (https=) |
| AU (1) | AU2022337284A1 (https=) |
| CA (1) | CA3230300A1 (https=) |
| MX (1) | MX2024002684A (https=) |
| TW (1) | TW202323275A (https=) |
| WO (1) | WO2023034914A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025137102A1 (en) * | 2023-12-18 | 2025-06-26 | Vaxxinity, Inc. | Peptide immunogen compositions and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6906169B2 (en) * | 2001-05-25 | 2005-06-14 | United Biomedical, Inc. | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| EP1572894B1 (en) * | 2001-11-21 | 2016-04-13 | New York University | Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto |
| US8697082B2 (en) * | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| GB201512203D0 (en) * | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| EP3638298A4 (en) * | 2017-06-16 | 2021-05-05 | United Neuroscience | PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN-PROTEIN AND FORMULATIONS THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHIA |
-
2022
- 2022-09-01 JP JP2024514038A patent/JP2024534901A/ja active Pending
- 2022-09-01 TW TW111133232A patent/TW202323275A/zh unknown
- 2022-09-01 CN CN202280070314.1A patent/CN118119403A/zh active Pending
- 2022-09-01 MX MX2024002684A patent/MX2024002684A/es unknown
- 2022-09-01 WO PCT/US2022/075836 patent/WO2023034914A2/en not_active Ceased
- 2022-09-01 AU AU2022337284A patent/AU2022337284A1/en active Pending
- 2022-09-01 EP EP22865800.1A patent/EP4395894A4/en active Pending
- 2022-09-01 CA CA3230300A patent/CA3230300A1/en active Pending
- 2022-09-01 KR KR1020247010060A patent/KR20240055785A/ko active Pending
- 2022-09-01 US US18/688,196 patent/US20240358806A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210032318A1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| JP5558834B2 (ja) | シヌクレイノパチーおよびアミロイド形成疾患（ａｍｙｌｏｉｄｏｇｅｎｉｃｄｉｓｅａｓｅ）の予防および処置 | |
| JP6041917B2 (ja) | 疾患を治療するための化合物 | |
| EP1793855B1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| US9034337B2 (en) | Treatment and delay of outset of synucleinopathic and amyloidogenic disease | |
| US20080014194A1 (en) | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease | |
| US8697082B2 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| JP6196336B2 (ja) | シヌクレイノパチーおよびアミロイド形成疾患（ａｍｙｌｏｉｄｏｇｅｎｉｃｄｉｓｅａｓｅ）の予防および処置 | |
| EP1910829A2 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| US20160184416A1 (en) | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease | |
| JP2024534901A5 (https=) | ||
| US20040146521A1 (en) | Prevention and treatment of synucleinopathic disease | |
| CA3230300A1 (en) | Methods for the prevention and treatment of synucleinopathies | |
| RU2024108344A (ru) | Способы предотвращения и лечения синуклеинопатий | |
| US20240254211A1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1260628A1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1228767A1 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1228767B (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1184169B (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1138622B (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| HK1161102A (en) | Prevention and treatment of synucleinopathic disease |